BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31940636)

  • 1. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
    Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
    Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms.
    Zhang Y; Shang L; Zhang PP; Chen LH; Wang W; Fang C; Qiu M; Feng XY; Zhou L; Zhang M; Tan HY; Qiu XD; Wang H; Lin R; Zhang Q; Zeng YJ; Jin KZ; Yu XJ; Shen L; Chen MH; Li J; Li LP; Chen J
    Cancer Med; 2019 Sep; 8(11):5000-5011. PubMed ID: 31293053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Lu J; Zhao YJ; Zhou Y; He Q; Tian Y; Hao H; Qiu X; Jiang L; Zhao G; Huang CM;
    Br J Surg; 2020 Feb; 107(3):248-257. PubMed ID: 31971627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
    Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
    J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study.
    Marano L; Boccardi V; Braccio B; Esposito G; Grassia M; Petrillo M; Pezzella M; Porfidia R; Reda G; Romano A; Schettino M; Cosenza A; Izzo G; Di Martino N
    World J Surg Oncol; 2015 Jul; 13():215. PubMed ID: 26179492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
    Li X; Gou S; Liu Z; Ye Z; Wang C
    Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
    Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
    BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database.
    You Y; Jang JY; Kim SC; Yoon YS; Park JS; Cho CK; Park SJ; Yang JD; Lee WJ; Hong TH; Ahn KS; Jeong CY; Lee HK; Lee SE; Roh YH; Kim HJ; Kim H; Han IW
    Cancer Res Treat; 2019 Oct; 51(4):1639-1652. PubMed ID: 30999719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
    Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
    Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system.
    Zhang R; Guo Y; Wang Y; Hu L; Fang C; Yang Y; Yang X; Chen L; Chen J; Wang W; Sun X
    Cancer Med; 2023 Mar; 12(6):6623-6636. PubMed ID: 36394081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
    Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma.
    Zheng H; Zhao Y; He Q; Hao H; Tian Y; Zou B; Jiang L; Qiu X; Zhou Y; Li Z; Xu Y; Zhao G; Xue F; Li S; Fu W; Li Y; Zhou X; Li Y; Zhu Z; Chen J; Xu Z; Cai L; Li E; Li H; Xie J; Zheng C; Lu J; Li P; Huang C
    Gastric Cancer; 2021 Mar; 24(2):503-514. PubMed ID: 32915373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
    Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
    Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
    Jiang W; Zhao B; Li Y; Qi D; Wang D
    BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.
    Kim BS; Park YS; Yook JH; Kim BS
    Medicine (Baltimore); 2016 Jul; 95(30):e3977. PubMed ID: 27472674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
    Abdel-Rahman O
    Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.
    Yang M; Zeng L; Zhang Y; Wang WG; Wang L; Ke NW; Liu XB; Tian BL
    Medicine (Baltimore); 2015 Mar; 94(12):e660. PubMed ID: 25816036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.